These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 35882382)

  • 1. Prevalence of Apparent Treatment-Resistant Hypertension in ESKD Patients Receiving Peritoneal Dialysis.
    Vareta G; Georgianos PI; Vaios V; Sgouropoulou V; Georgianou EI; Leivaditis K; Mavromatidis K; Dounousi E; Papagianni A; Balaskas EV; Zebekakis PE; Liakopoulos V
    Am J Hypertens; 2022 Nov; 35(11):918-922. PubMed ID: 35882382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current apparent treatment-resistant hypertension in patients undergoing peritoneal dialysis: A multi-center cross-sectional study.
    Li D; Huo Z; Liu D; Gong N; Zhang F; Kong Y; Zhang Y; Su X; Xu Q; Feng J; Luo F; Wang C; Dou X; Sun G; Zhang D; Qin X; Zhang G; Lu F; Ai J
    J Clin Hypertens (Greenwich); 2022 Apr; 24(4):493-501. PubMed ID: 35235248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and characteristics of apparent treatment-resistant hypertension in older people in China: a cross-sectional study.
    Wu C; Wang Y; Zhang W; Li X; Wang L; Hui R
    Clin Exp Hypertens; 2019; 41(8):753-758. PubMed ID: 30512984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apparent Treatment Resistant Hypertension Among Stroke Survivors in Ghana.
    Sarfo FS; Ovbiagele B
    J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105401. PubMed ID: 33096498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and clinical characteristics of apparent therapy-resistant hypertension in patients with cardiovascular disease: a cross-sectional cohort study in secondary care.
    de Beus E; van der Sande NGC; Bots ML; Spiering W; Voskuil M; Visseren FLJ; Blankestijn PJ
    BMJ Open; 2017 Sep; 7(9):e016692. PubMed ID: 28882918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistant Hypertension, Time-Updated Blood Pressure Values and Renal Outcome in Type 2 Diabetes Mellitus.
    Viazzi F; Piscitelli P; Ceriello A; Fioretto P; Giorda C; Guida P; Russo G; De Cosmo S; Pontremoli R;
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28939716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistant hypertension and cardiovascular disease mortality in the US: results from the National Health and Nutrition Examination Survey (NHANES).
    Kaczmarski KR; Sozio SM; Chen J; Sang Y; Shafi T
    BMC Nephrol; 2019 Apr; 20(1):138. PubMed ID: 31023262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease: Report From the Chronic Renal Insufficiency Cohort Study.
    Thomas G; Xie D; Chen HY; Anderson AH; Appel LJ; Bodana S; Brecklin CS; Drawz P; Flack JM; Miller ER; Steigerwalt SP; Townsend RR; Weir MR; Wright JT; Rahman M;
    Hypertension; 2016 Feb; 67(2):387-96. PubMed ID: 26711738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health care fragmentation and blood pressure control among adults taking antihypertensive medication.
    Colvin CL; Safford MM; Muntner P; Colantonio LD; Kern LM
    Am J Manag Care; 2022 Mar; 28(3):108-115. PubMed ID: 35404546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of optimal treatment regimens in patients with apparent treatment-resistant hypertension based on office blood pressure in a community-based practice network.
    Egan BM; Zhao Y; Li J; Brzezinski WA; Todoran TM; Brook RD; Calhoun DA
    Hypertension; 2013 Oct; 62(4):691-7. PubMed ID: 23918752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National patterns in intensity and frequency of outpatient care for apparent treatment-resistant hypertension.
    Vemulapalli S; Deng L; Patel MR; Kilgore ML; Jones WS; Curtis LH; Irvin MR; Svetkey LP; Shimbo D; Calhoun DA; Muntner P
    Am Heart J; 2017 Apr; 186():29-39. PubMed ID: 28454830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Apparent Treatment-Resistant Hypertension in the United States.
    Carey RM; Sakhuja S; Calhoun DA; Whelton PK; Muntner P
    Hypertension; 2019 Feb; 73(2):424-431. PubMed ID: 30580690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apparent treatment-resistant hypertension: characteristics and prevalence in a real-world environment of an integrated health system.
    An J; Sim JJ; Calhoun DA; Liu R; Wei R; Zhou H; Luong T; Reynolds K
    J Hypertens; 2020 Aug; 38(8):1603-1611. PubMed ID: 32251197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, phenotypic characteristics and prognostic role of apparent treatment resistant hypertension in the German Chronic Kidney Disease (GCKD) study.
    Mielke J; Trucks-Jansen H; Schurmann C; Kotsis F; Köttgen A; Schneider MP; Eckardt KU; ; Freitag DF; Eitner F; Becker MS
    J Hum Hypertens; 2023 May; 37(5):345-353. PubMed ID: 35534618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular Health and Transition From Controlled Blood Pressure to Apparent Treatment Resistant Hypertension: The Jackson Heart Study and the REGARDS Study.
    Akinyelure OP; Sakhuja S; Colvin CL; Clark D; Jaeger BC; Hardy ST; Howard G; Cohen LP; Irvin MR; Tanner R; Carey RM; Muntner P
    Hypertension; 2020 Dec; 76(6):1953-1961. PubMed ID: 33131312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apparent Treatment Resistant Hypertension, Blood Pressure Control and the Progression of Chronic Kidney Disease in Patients with Type 2 Diabetes.
    Viazzi F; Greco E; Ceriello A; Fioretto P; Giorda C; Guida P; Russo G; De Cosmo S; Pontremoli R;
    Kidney Blood Press Res; 2018; 43(2):422-438. PubMed ID: 29698970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of nocturnal hypertension and nondipping blood pressure with treatment-resistant hypertension: The Jackson Heart Study.
    Irvin MR; Booth JN; Sims M; Bress AP; Abdalla M; Shimbo D; Calhoun DA; Muntner P
    J Clin Hypertens (Greenwich); 2018 Mar; 20(3):438-446. PubMed ID: 29436105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychosocial correlates of apparent treatment-resistant hypertension in the Jackson Heart Study.
    Shallcross AJ; Butler M; Tanner RM; Bress AP; Muntner P; Shimbo D; Ogedegbe G; Sims M; Spruill TM
    J Hum Hypertens; 2017 Jul; 31(7):474-478. PubMed ID: 28124682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Muntner P; Davis BR; Cushman WC; Bangalore S; Calhoun DA; Pressel SL; Black HR; Kostis JB; Probstfield JL; Whelton PK; Rahman M;
    Hypertension; 2014 Nov; 64(5):1012-21. PubMed ID: 25259745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation and Apparent Treatment-Resistant Hypertension in Patients With Chronic Kidney Disease.
    Chen J; Bundy JD; Hamm LL; Hsu CY; Lash J; Miller ER; Thomas G; Cohen DL; Weir MR; Raj DS; Chen HY; Xie D; Rao P; Wright JT; Rahman M; He J
    Hypertension; 2019 Apr; 73(4):785-793. PubMed ID: 30776971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.